230 related articles for article (PubMed ID: 34640387)
21. Factors Associated with Alzheimer's Disease: An Overview of Reviews.
Rochoy M; Rivas V; Chazard E; Decarpentry E; Saudemont G; Hazard PA; Puisieux F; Gautier S; Bordet R
J Prev Alzheimers Dis; 2019; 6(2):121-134. PubMed ID: 30756119
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress and metabolic syndrome.
Roberts CK; Sindhu KK
Life Sci; 2009 May; 84(21-22):705-12. PubMed ID: 19281826
[TBL] [Abstract][Full Text] [Related]
23. A review of the mechanisms underlying selected comorbidities in Alzheimer's disease.
Maciejewska K; Czarnecka K; Szymański P
Pharmacol Rep; 2021 Dec; 73(6):1565-1581. PubMed ID: 34121170
[TBL] [Abstract][Full Text] [Related]
24. [Risk assessment for sleep apnea syndrome and excessive daytime sleepiness in patients with chronic obstructive pulmonary disease].
Maricić L; Visević R; Vceva A; Vcev A; Labor S
Acta Med Croatica; 2013 Jun; 67(3):219-24. PubMed ID: 25007431
[TBL] [Abstract][Full Text] [Related]
25. Investigation of common risk factors between polycystic ovary syndrome and Alzheimer's disease: a narrative review.
Sarahian N; Sarvazad H; Sajadi E; Rahnejat N; Eskandari Roozbahani N
Reprod Health; 2021 Jul; 18(1):156. PubMed ID: 34311759
[TBL] [Abstract][Full Text] [Related]
26. Potential active compounds and common mechanisms of Evodia rutaecarpa for Alzheimer's disease comorbid pain by network pharmacology analysis.
Jiang H; Qiu J; Deng X; Li D; Tao T
Heliyon; 2023 Aug; 9(8):e18455. PubMed ID: 37529338
[No Abstract] [Full Text] [Related]
27. Non-psychiatric comorbidity associated with Alzheimer's disease.
Duthie A; Chew D; Soiza RL
QJM; 2011 Nov; 104(11):913-20. PubMed ID: 21768167
[TBL] [Abstract][Full Text] [Related]
28. microRNA pathological mechanisms between Parkinson's disease, Alzheimer's disease, glaucoma and macular degeneration.
Wang H
Expert Rev Mol Med; 2023 Jul; 25():e24. PubMed ID: 37469309
[TBL] [Abstract][Full Text] [Related]
29. Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer's disease-induced estrogen deficient rats.
Shin BK; Kang S; Kim DS; Park S
Exp Biol Med (Maywood); 2018 Feb; 243(4):334-343. PubMed ID: 29307281
[TBL] [Abstract][Full Text] [Related]
30. Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.
Kapoor A; Bartha R; Black SE; Borrie M; Freedman M; Gao F; Herrmann N; Mandzia J; Ozzoude M; Ramirez J; Scott CJM; Symons S; Fischer CE; Frank A; Seitz D; Wolf MU; Verhoeff NPLG; Naglie G; Reichman W; Masellis M; Mitchell SB; Tang-Wai DF; Tartaglia MC; Kumar S; Pollock BG; Rajji TK; Finger E; Pasternak SH; ; Swartz RH
J Alzheimers Dis; 2020; 74(3):747-757. PubMed ID: 32116253
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors and Pathological Substrates Associated with Agitation/Aggression in Alzheimer's Disease: A Preliminary Study using NACC Data.
Sennik S; Schweizer TA; Fischer CE; Munoz DG
J Alzheimers Dis; 2017; 55(4):1519-1528. PubMed ID: 27911311
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders.
Islam MT
Neurol Res; 2017 Jan; 39(1):73-82. PubMed ID: 27809706
[TBL] [Abstract][Full Text] [Related]
33. The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer's Disease.
Ojala JO; Sutinen EM
J Clin Med; 2017 May; 6(5):. PubMed ID: 28531131
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular and metabolic comorbidities in patients with Alzheimer's disease and vascular dementia compared to a psychiatric control cohort.
Vogelgsang J; Wolff-Menzler C; Kis B; Abdel-Hamid M; Wiltfang J; Hessmann P
Psychogeriatrics; 2018 Sep; 18(5):393-401. PubMed ID: 29993172
[TBL] [Abstract][Full Text] [Related]
35. The Potential of 'Omics to Link Lipid Metabolism and Genetic and Comorbidity Risk Factors of Alzheimer's Disease in African Americans.
Stepler KE; Robinson RAS
Adv Exp Med Biol; 2019; 1118():1-28. PubMed ID: 30747415
[TBL] [Abstract][Full Text] [Related]
36. Global View on Alzheimer's Disease and Diabetes Mellitus: Threats, Risks and Treatment Alzheimer's Disease and Diabetes Mellitus.
Klimova B; Kuca K; Maresova P
Curr Alzheimer Res; 2018; 15(14):1277-1282. PubMed ID: 30251605
[TBL] [Abstract][Full Text] [Related]
37. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer's disease.
Spina S; La Joie R; Petersen C; Nolan AL; Cuevas D; Cosme C; Hepker M; Hwang JH; Miller ZA; Huang EJ; Karydas AM; Grant H; Boxer AL; Gorno-Tempini ML; Rosen HJ; Kramer JH; Miller BL; Seeley WW; Rabinovici GD; Grinberg LT
Brain; 2021 Aug; 144(7):2186-2198. PubMed ID: 33693619
[TBL] [Abstract][Full Text] [Related]
38. The neuroprotective effects of oxygen therapy in Alzheimer's disease: a narrative review.
Yang C; Yang Q; Xiang Y; Zeng XR; Xiao J; Le WD
Neural Regen Res; 2023 Jan; 18(1):57-63. PubMed ID: 35799509
[TBL] [Abstract][Full Text] [Related]
39. Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls.
Filippov MA; Tatarnikova OG; Pozdnyakova NV; Vorobyov VV
Neural Regen Res; 2021 Feb; 16(2):223-233. PubMed ID: 32859768
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]